Clinical Efficacy of Thumbtack Needle for Chronic Insomnia in Perimenopausal and Menopausal Women
Starting soon · Not applicable · Has a placebo group
Conditions studied: Chronic Insomnia During Perimenopause and Menopause
In brief
A multicenter, randomized, controlled, blinded clinical trial was conducted to evaluate the effects of thumbtack needle on sleep in patients with chronic insomnia during perimenopause and menopause. Randomly divided into a treatment group and a control group using the central area method, with 99 patients in each group. The treatment group received thumbtack needle treatment, while the control group received placebo thumbtack needle treatment. The treatment course for both groups was 4 weeks.
Key facts
- Study ID
- NCT07229976
- Run by
- Huazhong University of Science and Technology
- People needed
- 198
- Starts
- 2026-03-20
- Expected to finish
- 2029-12-30
- Last updated by the study team
- 2026-03-17
Who can join
Age: 40 and older, up to 65. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women aged 40 to 65 who meet the diagnostic criteria for perimenopause and menopause mentioned above;
- Evaluate ISI score ≥ 12 points through a scale;
- Meets the diagnostic criteria for chronic insomnia mentioned above, i.e. ICSD-3 meets both criteria A to F;
- Voluntarily participate in this study and sign an informed consent form.
You may not qualify if…
- Patients who meet any of the following conditions will not be included;
- Use hormone replacement therapy, anti anxiety drugs, antidepressants, or medications to improve insomnia within one month;
- Individuals with a history of diagnosed sleep disorders before menopause;
- Combined with other sleep disorders such as obstructive sleep apnea, restless leg syndrome, etc;
- Patients with malignant tumors, especially estrogen dependent tumors (such as breast cancer and endometrial cancer);
- Recent (within 6 months) history of myocardial infarction, stroke, venous thrombosis, etc;
- Patients with mental illnesses, such as severe depression and uncontrolled schizophrenia;
- Serious disorder of endocrine system, such as uncontrolled hyperthyroidism, diabetes ketoacidosis, etc
- Patients with coagulation disorders, such as hemophilia, long-term use of anticoagulants (warfarin, aspirin, etc.), etc;
- Long term alcohol consumption history (more than 5 years, daily alcohol consumption exceeding 12 taels, not quitting drinking);
- Engaged in night shift work (>3 times a week);
- Individuals with infections, ulcers, burns, rashes, or scars at acupoints;
- Previously received acupuncture treatment;
- I do not agree to sign the informed consent form for this study.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.